Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Mental Disorders
Resources
Basic InformationLookupsLatest News
Pets Good Medicine for Those Battling Mental IllsLimited Evidence for Effect of Cranial Electrical StimulationVirtual Reality-Based CBT Beneficial for Psychotic DisordersAutism, Bipolar and Schizophrenia Share Genetic SimilaritiesSubstantial Unmet Need for Mental Health Care for VeteransMental Health Care Access Differs With Race, InsuranceVA Health System Failing on Mental Health Care: ReportSevere Bullying Tied to Mental Health Woes in TeensMore Sought Mental Health Specialty Care in 2008 to 2015'Mountain Madness' Found to Be a Real PsychosisHealth Tip: Stay WellTaking Your Meds? A Digital Pill Can TellFDA OKs First 'Digital Pill' That Lets Doctors Know It's Been TakenIs Too Much Time Online Raising Suicide Risk in Teen Girls?Childhood Spanking Could Heighten Adult Mental Health WoesSurgical Residents Prime Candidates for Stress, Depression, Alcohol AbuseMedical License Questions Sway Doctors' Mental Health HelpAmericans More Open About Mental Health Issues, But Stigma LingersNarrow Networks in ACA Marketplace for Mental HealthHurricanes' Toll on Mental Health Will LingerER Visits for These 3 Health Woes Don't Have to HappenPreventive Psychological, Educational Programs BeneficialPsychosocial Intervention App Feasible in Serious Mental IllnessHealth Tip: Mental Disorders Are CommonNearly 1 in 5 U.S. Adults Has Mental Illness or Drug ProblemHalf of Opioid Prescriptions Go to People With Mental IllnessPsychological Risks Higher in Atopic Dermatitis PatientsSAMHSA: 9.8 Million U.S. Adults Have Serious Mental IllnessNearly 10 Million U.S. Adults Suffer From Mental IllnessSuicide Risk Is High for Psychiatric Patients Long After Discharge From CareStreptococcal Throat Infection Linked to Mental DisordersMental Health Myths Abound in the U.S.Care Access Worsening for Adults With Psychological DistressJust 1 in 5 Mentally Ill Women Gets Cervical Cancer ScreeningsAnxious? Distressed? You're Not AlonePast Psychiatric Disorders Do Not Raise Risk of Alzheimer's DiseasePast Psychiatric Ills Don't Raise Alzheimer's Risk: StudySelf-Harm Can Be a Harbinger of SuicideClimate Change May Cloud Americans' Mental Health: ReportKetamine Beneficial for Certain Patients With Mood DisordersPatients Reluctant to Comply With Drug-Only Psychiatric TreatmentPatients Often Reject Drug-Only Psychiatric TreatmentU.S. Soldier in Custody Following Slaying of 5 Americans in Iraq
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Bipolar Disorder
Depression: Depression & Related Conditions
Schizophrenia
Eating Disorders
Medications

Limited Evidence for Effect of Cranial Electrical Stimulation


HealthDay News
Updated: Feb 12th 2018

new article illustration

MONDAY, Feb. 12, 2018 (HealthDay News) -- Evidence for the effectiveness of cranial electrical stimulation (CES) is sparse, according to a review published online Feb. 13 in the Annals of Internal Medicine.

Paul G. Shekelle, M.D., Ph.D., from the West Los Angeles Veterans Affairs Medical Center, and colleagues reviewed evidence relating to the benefits and harms of CES for adults with chronic painful conditions, depression, anxiety, and insomnia. Data were included for 28 articles from 26 randomized trials that met the eligibility criteria.

The researchers found that the two trials that compared CES with usual care were small, and no statistically significant benefit was reported in pain or anxiety outcomes among those with fibromyalgia or anxiety, respectively. Conflicting results were observed in 14 trials with sham or placebo controls involving patients with painful conditions such as headache, neuromuscular pain, or musculoskeletal pain. In patients with anxiety and depression, low-strength evidence of a possible modest benefit was seen in four trials conducted more than 40 years ago and in one recent trial compared with sham treatments. Inconclusive or conflicting results were seen in trials with patients with insomnia (two trials), insomnia and anxiety (one trial), or depression (three trials).

"Evidence is insufficient that CES has clinically important effects on fibromyalgia, headache, neuromusculoskeletal pain, degenerative joint pain, depression, or insomnia; low-strength evidence suggests modest benefit in patients with anxiety and depression," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)